FDA NDC Directory · JSON-LD · Markdown

Talzenna

NDC 63539-051 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nametalazoparib
Labeler / ManufacturerU.S. Pharmaceuticals
Marketing categoryNew Drug Application (innovator) · App NDA211651
Dosage form / routeCAPSULE · ORAL
Active ingredientsTALAZOPARIB TOSYLATE (.5 mg/1)
Marketing started20230621
Marketing ended20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).